Linolelaidic acid

Linolelaidic acid (Linoelaidic acid) is an omega-6 trans fatty acid (TFA) that is an essential nutrient with oral activity. Linolelaidic acid can be added to enteral nutrition (oral), parenteral nutrition (intravenous), and infant formula. Linolelaidic acid has anti-inflammatory and anti-parasitic ((Parasite) ) activities, and can induce Apoptosis. Linolelaidic acid is useful for research in infections[1][2][3].

Product Specifications

CAS Number

[506-21-8]

Product Name Alternative

Linoelaidic acid

UNSPSC

12352211

Hazard Statement

H302, H315, H319, H335

Target

Apoptosis; Endogenous Metabolite; Parasite

Type

Natural Products

Related Pathways

Anti-infection; Apoptosis; Metabolic Enzyme/Protease

Applications

Neuroscience-Neuromodulation

Field of Research

Infection; Inflammation/Immunology

Assay Protocol

https://www.medchemexpress.com/linolelaidic-acid.html

Purity

99.52

Solubility

DMSO : 125 mg/mL (ultrasonic)

Smiles

CCCCC/C=C/C/C=C/CCCCCCCC(O)=O

Molecular Formula

C18H32O2

Molecular Weight

280.45

Precautions

H302, H315, H319, H335

References & Citations

[1]Jay Whelan, et al. Linoleic acid. Adv Nutr. 2013 May 1;4 (3) :311-2.|[2]Melariri P, et al. In vitro and in vivo antimalarial activity of linolenic and linoleic acids and their methyl esters[J]. Adv Stud Biol, 2012, 4 (7) : 333-49.|[3]Li J, et al. Linolelaidic acid induces apoptosis, cell cycle arrest and inflammation stronger than elaidic acid in human umbilical vein endothelial cells through lipid rafts[J]. European Journal of Lipid Science and Technology, 2017, 119 (7) : 1600374.